 BOSTON, MA ACCESSWIRE October 26, 2021 Pieris Pharmaceuticals, Inc. NASDAQ: PIRS , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases, cancer and other indications, today announced that it will host a third quarter 2021 investor call on Tuesday, November 2, 2021 at 8:00 AM EDT to discuss financial results and provide a corporate update. To access the call, participants may dial 877-407-8920 Toll Free US Canada or 412-902-1010 International at least five minutes prior to the start of the call. 